Vimarsana
Biggest News Aggregation in the World

Page 45 - Genetics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genetics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genetics Inc Today - Breaking & Trending Today

Myriad Genetics (NASDAQ:MYGN) Upgraded to Buy at The Goldman Sachs Group - Vimarsana News

Myriad Genetics (NASDAQ:MYGN) Upgraded to Buy at The Goldman Sachs Group

The Goldman Sachs Group upgraded shares of Myriad Genetics (NASDAQ:MYGN – Get Rating) from a sell rating to a buy rating in a research report sent to investors on Tuesday, The Fly reports. They currently have $25.00 target price on the stock, up from their prior target price of $18.00. MYGN has been the subject […]

Mirae Asset Global Investments Co. Ltd. Sells 74,151 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN) - Vimarsana News

Mirae Asset Global Investments Co. Ltd. Sells 74,151 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)

Mirae Asset Global Investments Co. Ltd. decreased its stake in Myriad Genetics, Inc. (NASDAQ:MYGN – Get Rating) by 18.6% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 325,422 shares of the company’s stock after selling 74,151 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Myriad Genetics were worth […]

Myriad Genetics Adds Folate Receptor Alpha to Precise™ Oncology Solutions Portfolio to Expand Treatment Options for Women Living with Ovarian Cancer - Vimarsana News

Myriad Genetics Adds Folate Receptor Alpha to Precise™ Oncology Solutions Portfolio to Expand Treatment Options for Women Living with Ovarian Cancer

Biomarker offers another companion diagnostic option to establish eligibility for FDA-approved drug ELAHERE® SALT LAKE CITY, May 24, 2023 -- Myriad Genetics, Inc. , a leader in genetic testing... | June 11, 2023

Myriad Genetics Adds Folate Receptor Alpha to Precise Oncology Solutions Portfolio to Expand Treatment Options for Women Living with Ovarian Cancer - Vimarsana News

Myriad Genetics Adds Folate Receptor Alpha to Precise Oncology Solutions Portfolio to Expand Treatment Options for Women Living with Ovarian Cancer

24.05.2023 - Biomarker offers another companion diagnostic option to establish eligibility for FDA-approved drug ELAHERE SALT LAKE CITY, May 24, 2023 (GLOBE NEWSWIRE) - Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, ...

Carrier Screening Global Market Report 2023: Increase in Fetal Chromosomal Abnormalities Drives Growth - Vimarsana News

Carrier Screening Global Market Report 2023: Increase in Fetal Chromosomal Abnormalities Drives Growth

/PRNewswire/ -- The "Carrier Screening Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...